Caltagirone SpA (CALT)
Sep 20, 2024 - CALT was voluntarily delisted
40.00
-0.04 (-0.10%)
Inactive · Last trade price on Sep 20, 2024
CALT Employees
As of December 31, 2024, Caltagirone SpA had 3,925 total employees, including 3,823 full-time and 102 part-time employees. The number of employees increased by 176 or 4.69% compared to the previous year.
Employees
3,925
Change (1Y)
176
Growth (1Y)
4.69%
Revenue / Employee
$563,963
Profits / Employee
$34,760
Market Cap
988.36M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3,925 | 176 | 4.69% |
Dec 31, 2023 | 3,749 | 18 | 0.48% |
Dec 31, 2022 | 3,731 | 11 | 0.30% |
Dec 31, 2021 | 3,720 | 17 | 0.46% |
Dec 31, 2019 | 3,703 | -203 | -5.20% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
CALT News
- 11 months ago - Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm - PRNewsWire
- 11 months ago - Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) - PRNewsWire
- 11 months ago - Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei - PRNewsWire
- 1 year ago - Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Calliditas Interim Report January to June 2024 - PRNewsWire
- 1 year ago - Number of shares and votes in Calliditas Therapeutics - PRNewsWire
- 1 year ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders - Accesswire
- 1 year ago - Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy - PRNewsWire